MARKSANSPharmaceuticals
Marksans Pharma Ltd — Quarterly Results & Earnings
₹156.89
-1.28%
Profit Growth YoY1.58%Latest quarter
Sales Growth YoY12.23%Latest quarter
Sales CAGR 5Y18.25%5 year compound
Profit CAGR 5Y25.78%5 year compound
📋
Quarterly Performance
YoY Profit Growth+1.58%
📈 Moderate growth
YoY Sales Growth+12.23%
✅ Strong growth
OPM 5Y Average
20.23%Operating profit margin
EPS Growth 5Y
23.25%Interest Coverage
27.07Higher = safer debt servicing
ROE
16.77%ROCE
20.03%💡
Growth Analysis
Marksans Pharma Ltd reported YoY profit growth of 1.58% and revenue growth of 12.23% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 18.25% and profits at 25.78% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Marksans Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.